Annual Operating Expenses
$828.62 M
-$26.58 M-3.11%
December 31, 2024
Summary
- As of March 10, 2025, APLS annual total operating expenses is $828.62 million, with the most recent change of -$26.58 million (-3.11%) on December 31, 2024.
- During the last 3 years, APLS annual operating expenses has risen by +$230.98 million (+38.65%).
- APLS annual operating expenses is now -3.11% below its all-time high of $855.20 million, reached on December 31, 2023.
Performance
APLS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$197.84 M
-$12.72 M-6.04%
December 31, 2024
Summary
- As of March 10, 2025, APLS quarterly total operating expenses is $197.84 million, with the most recent change of -$12.72 million (-6.04%) on December 31, 2024.
- Over the past year, APLS quarterly operating expenses has stayed the same.
- APLS quarterly operating expenses is now -12.10% below its all-time high of $225.07 million, reached on September 30, 2023.
Performance
APLS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
APLS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -3.1% | 0.0% |
| 3 y3 years | +38.6% | +36.8% |
| 5 y5 years | +187.7% | +36.8% |
APLS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -3.1% | +38.6% | -12.1% | +39.2% |
| 5 y | 5-year | -3.1% | +187.7% | -12.1% | +108.6% |
| alltime | all time | -3.1% | >+9999.0% | -12.1% | +7313.5% |
Apellis Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $828.62 M(-3.1%) | $197.84 M(-6.0%) |
| Sep 2024 | - | $210.55 M(+2.2%) |
| Jun 2024 | - | $206.03 M(-3.8%) |
| Mar 2024 | - | $214.21 M(+1.5%) |
| Dec 2023 | $855.20 M(+28.7%) | $210.98 M(-6.3%) |
| Sep 2023 | - | $225.07 M(+8.7%) |
| Jun 2023 | - | $207.03 M(-2.4%) |
| Mar 2023 | - | $212.12 M(+15.4%) |
| Dec 2022 | $664.40 M(+11.2%) | $183.79 M(+5.9%) |
| Sep 2022 | - | $173.61 M(+5.3%) |
| Jun 2022 | - | $164.86 M(+16.0%) |
| Mar 2022 | - | $142.13 M(-1.7%) |
| Dec 2021 | $597.64 M(+36.0%) | $144.64 M(+8.4%) |
| Sep 2021 | - | $133.50 M(-31.5%) |
| Jun 2021 | - | $194.91 M(+56.4%) |
| Mar 2021 | - | $124.59 M(+31.4%) |
| Dec 2020 | $439.32 M | $94.83 M(-27.2%) |
| Sep 2020 | - | $130.20 M(+12.7%) |
| Jun 2020 | - | $115.51 M(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $98.79 M(-6.8%) |
| Dec 2019 | $288.01 M(+125.1%) | $105.94 M(+51.5%) |
| Sep 2019 | - | $69.95 M(+10.2%) |
| Jun 2019 | - | $63.48 M(+30.5%) |
| Mar 2019 | - | $48.65 M(+30.8%) |
| Dec 2018 | $127.92 M(+152.0%) | $37.20 M(+3.9%) |
| Sep 2018 | - | $35.80 M(+6.9%) |
| Jun 2018 | - | $33.49 M(+56.2%) |
| Mar 2018 | - | $21.44 M(+19.1%) |
| Dec 2017 | $50.77 M(+86.1%) | $17.99 M(+55.3%) |
| Sep 2017 | - | $11.59 M(-4.5%) |
| Jun 2017 | - | $12.13 M(+34.0%) |
| Mar 2017 | - | $9.05 M(+35.5%) |
| Dec 2016 | $27.28 M(+35.8%) | $6.68 M(-7.7%) |
| Sep 2016 | - | $7.23 M(+3.9%) |
| Dec 2015 | $20.09 M(+77.9%) | $6.96 M(+35.0%) |
| Sep 2015 | - | $5.16 M(+76.9%) |
| Dec 2014 | $11.29 M(+180.3%) | $2.92 M(+9.3%) |
| Sep 2014 | - | $2.67 M |
| Dec 2013 | $4.03 M | - |
FAQ
- What is Apellis Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals annual operating expenses year-on-year change?
- What is Apellis Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Apellis Pharmaceuticals?
- What is Apellis Pharmaceuticals quarterly operating expenses year-on-year change?
What is Apellis Pharmaceuticals annual total operating expenses?
The current annual operating expenses of APLS is $828.62 M
What is the all time high annual operating expenses for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high annual total operating expenses is $855.20 M
What is Apellis Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, APLS annual total operating expenses has changed by -$26.58 M (-3.11%)
What is Apellis Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of APLS is $197.84 M
What is the all time high quarterly operating expenses for Apellis Pharmaceuticals?
Apellis Pharmaceuticals all-time high quarterly total operating expenses is $225.07 M
What is Apellis Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, APLS quarterly total operating expenses has changed by $0.00 (0.00%)